Lymphedema Act of 2024: Overview and Implications

Published by Acibadem Health Point Last updated June 3, 2025

Lymphedema Act of 2024: Overview and Implications The Lymphedema Treatment Act (LTA) became effective on January 1, 2024, marking a significant milestone for patients across the United States. This legislation introduces Medicare coverage for essential compression supplies, addressing a long-standing gap in healthcare access.

Heather Ferguson, founder of the Lymphedema Advocacy Group, played a pivotal role in this achievement. Her 13-year grassroots campaign brought attention to the needs of patients, ensuring their voices were heard in Congress. The law’s implementation reflects a dual focus: improving patient access and outlining responsibilities for healthcare providers.

Introduction to the Lymphedema Act of 2024

A significant legislative change brings hope to millions with chronic conditions. Signed into law on December 23, 2022, this reform marks the culmination of over a decade of advocacy. Efforts began in 2010, with more than 40 organizations collaborating to push for essential coverage improvements.

Over 10 million Americans are affected by this chronic condition, which requires lifelong management. The new law addresses a critical gap in healthcare access, ensuring patients receive the necessary support. For many, this includes vital supplies like compression garments and bandaging materials.

The transition from legislative victory to practical implementation has not been without challenges. Healthcare providers and patients alike must adapt to the new medicare coverage guidelines. This shift is particularly important for cancer survivors and those with congenital conditions, who often face significant barriers to care.

This reform represents a major step forward in managing chronic conditions. By addressing long-standing issues, it aims to improve quality of life for millions. The law’s impact will continue to unfold as it went effect on January 1, 2024, reshaping the landscape of lymphedema treatment in the U.S.

What is the Lymphedema Act of 2024?

Millions of Americans now have access to critical resources thanks to new legislation. This law ensures patients receive essential compression garments and other necessary supplies for managing chronic conditions. It addresses long-standing gaps in medicare coverage, providing relief to those in need.

Key Provisions of the Act

The law outlines specific coverage details for patients. Here’s what you need to know:

Compression Garments: Patients can receive up to three daytime garments per affected body part every six months. Nighttime garments are limited to two every two years.
Standard vs. Custom-Fit: Standard-fit garments are covered without additional requirements. Custom-fit options require clinical notes to justify their necessity.
Bandaging Supplies: Unlimited bandages and accessories are covered for decongestive therapy, ensuring patients have what they need for effective treatment.
Adjustable Wraps: These items are included in the coverage, providing flexibility for patients during therapy.
Exclusions: Pumps and surgeries are not covered under this law, as they fall under other Medicare benefits.

This comprehensive approach ensures patients have access to the tools they need for better health outcomes. Lymphedema Act of 2024: Overview and Implications

Impact on Medicare Coverage

Patients managing chronic conditions now benefit from expanded Medicare coverage. The new guidelines ensure access to essential supplies, addressing long-standing gaps in care. This change is particularly impactful for those requiring lifelong management of their condition.

Coverage for Compression Garments

The updated policy includes specific provisions for compression garments. Patients can receive up to three daytime garments per affected body part every six months. Nighttime garments are limited to two every two years, a change from the initial proposal of five years.

Standard-fit garments are covered without additional requirements. For custom-fit options, clinical notes are necessary to justify their use. This ensures patients receive the most appropriate support for their needs.

Bandaging Supplies and Accessories

Unlimited bandages and accessories are now covered for decongestive therapy. This includes items like adjustable wraps, which provide flexibility during treatment. The coverage also extends to the maintenance phase, ensuring continuous support for patients.

To qualify, patients must have specific ICD-10 codes, such as I89.0, Q82.0, I97.2, or I97.89. New HCPCS codes have been created for billing, including 50 daytime and 16 bandaging codes. Suppliers must adhere to DMEPOS standards, ensuring proper documentation and compliance. Lymphedema Act of 2024: Overview and Implications

ICD-10 Codes: Required for Medicare eligibility, including I89.0 and Q82.0.
HCPCS Codes: New codes for billing different garment types and bandaging supplies.
Documentation: Suppliers must follow DMEPOS standards for compliance.

Role of Healthcare Providers

Healthcare providers play a critical role in ensuring patients receive proper care under the new guidelines. Their responsibilities include verifying diagnosis, issuing accurate prescriptions, and coordinating with certified therapists. This process ensures patients have access to the necessary supplies for effective management of their condition.

Diagnosis and Prescription Requirements

Providers must document the diagnosis in medical records and specify the type of garment in the prescription. Missing details, such as the affected body part, can lead to delays in care. Clinical notes are also required for custom-fit garments, ensuring patients receive the most appropriate support.

Billing and Coding Updates

New CMS billing guidelines, effective March 2024, introduce updated protocols for suppliers of durable medical equipment. Noridian MAC has revised claim processing procedures, requiring strict adherence to documentation standards. Suppliers must also meet CMS accreditation requirements to ensure compliance.

Step-by-step provider responsibilities: verify diagnosis → issue prescription → include clinical notes.
Billing updates: Follow Noridian MAC’s revised claim processing protocols.
Accreditation: Suppliers must meet CMS quality standards.
Common errors: Avoid incomplete prescriptions, such as missing body part details.
Coordination: Work closely with certified therapists for seamless patient care.

Implications for Non-Medicare Patients

Private insurance companies are expected to follow Medicare’s lead in coverage changes. This shift could significantly impact non-Medicare patients, expanding their access to essential services. Heather Ferguson, a leading advocate, recommends obtaining prescriptions to streamline coverage requests with insurers.

Potential Changes in Private Insurance

Lymphedema Act of 2024: Overview and Implications Historically, 87% of private insurers align with Medicare coverage within 18 months. This trend suggests that many patients with private plans could soon benefit from similar provisions. Preventive compression therapy, for example, may become more widely covered, reducing long-term complication costs for insurers.

Here’s what patients and providers should know:

Adoption Rates: Most private insurers are projected to adopt Medicare’s guidelines by mid-2025.
Cost-Benefit Analysis: Covering preventive measures like compression garments can lower overall healthcare expenses by avoiding costly complications.
State-Specific Variations: Medicaid coverage differs by state, so patients should verify local policies.
Appeal Strategies: Sample appeal language can help patients contest denied claims effectively.
Advocacy Tips: Patients are encouraged to engage with employers and insurers to advocate for comprehensive coverage.

For non-Medicare patients, staying informed and proactive is key. Understanding insurance plans and leveraging advocacy resources can help ensure access to necessary services.

Advocacy and Awareness Efforts

Grassroots movements continue to drive meaningful change in healthcare. The lymphedema advocacy group has been at the forefront, providing essential resources and tracking coverage denials. Their efforts ensure patients and providers have the information needed to navigate new policies effectively. Lymphedema Act of 2024: Overview and Implications

Role of Advocacy Groups

Heather Ferguson, a leading advocate, works closely with CMS to address implementation gaps. Her ongoing efforts highlight the role of advocacy in shaping patient care. The lymphedema advocacy group offers toolkits and resources, empowering patients to access necessary treatments.

Key initiatives include:

Provider education through partnerships with ASCO and APTA.
Patient success stories showcasing improved quality of life.
Digital tools like social media templates and legislative contact forms.

Educating Patients and Providers

Education is critical for successful policy implementation. Triage Cancer offers CME courses to help providers understand the new guidelines. These initiatives ensure patients receive the best possible care.

Upcoming events during Lymphedema Awareness Month (March) will further promote awareness. These efforts aim to bridge gaps in knowledge and support for those affected.

Future of Lymphedema Treatment in the U.S.

The future of managing chronic conditions in the U.S. looks promising with recent advancements. Improved access to compression therapy is projected to reduce hospitalizations for related complications by 32%. This progress highlights the importance of ongoing care and treatment innovations.

Long-term Benefits and Challenges

One of the most significant benefits is the potential for $2.1 billion in annual Medicare savings. This cost reduction comes from fewer hospital visits and better management of the condition. Emerging technologies, such as advanced compression devices, are also complementing traditional therapies.

However, challenges remain. Rural areas face supplier shortages, and prior authorization delays can hinder timely access to care. Addressing these issues will be critical for ensuring equitable treatment across the country.

Continued Advocacy and Policy Development

Advocacy groups are working to expand coverage to Medicaid and VA systems. Pending legislation aims to include conditions like lipedema and phlebolymphedema. These efforts could benefit millions more in the coming years.

Research initiatives are also tracking patient outcomes under the new guidelines. This data will help refine policies and improve medicare coverage lymphedema programs. Continued collaboration between patients, providers, and policymakers will be essential for sustained progress.

Looking Ahead: The Lymphedema Act of 2024

Lymphedema Act of 2024: Overview and Implications As the healthcare landscape evolves, the recent legislative changes mark a pivotal moment for patient care. The lymphedema treatment act has set the stage for improved coverage, with CMS planning a full policy review in 2026. Advocacy groups are closely monitoring risks in the Competitive Bidding Program to ensure patient access remains uninterrupted.

Key milestones include updates to DME enrollment in 2024 and the upcoming CMS review. Patients are encouraged to stay informed and proactive in navigating these changes. Providers must continue their education on coding updates to ensure seamless care delivery.

This U.S. model could also influence international policies, setting a precedent for comprehensive coverage worldwide. Readers are urged to engage with advocacy efforts to support ongoing improvements in patient care.